An Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion
Launched by UNIVERSITY OF EAST ANGLIA · Aug 12, 2013
Trial Information
Current as of May 30, 2025
Unknown status
Keywords
ClinConnect Summary
The study will recruit men and women who are aged either 18-30 or 65-77 years and are generally healthy.On arriving at the study day we will collect a blood sample. Breakfast will then be supplied in the form of a food or drink that will contain freezedried powder from orange juice, chocolate and blackberry. After breakfast further blood samples will be taken at several time points throughout the day. Urine and faeces samples will also be collected. These biological samples will be tested for flavonoid absorption, metabolism and excretion as well as influence of genetic make-up of individua...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or Female
- • Caucasian of European origin
- • Age either between 18-30 years or between 65-77 years
- Exclusion Criteria:
- • BMI \< 18.5 kg/m2 or BMI \> 30 kg/m2
- • Smokers or nicotine users
- • High (above 140/90 mmHg ) or low (less than 90/60 mmHg) blood pressure
- • Having any existing medical conditions or significant past medical history likely to affect study measurements e.g., type 2 diabetes, cardiovascular, renal, liver or gastrointestinal diseases
- • Unsatisfactory biochemical, haematological or urinary assessment, indicating abnormal; renal or liver function, full blood profile, impaired glucose handling, deranged lipids or measurements considered to be counter indicative of the study by the clinical advisor
- • Taking any prescribed medication that could interact with the enzymes involved in the metabolism of flavonoids
- • Taking flavonoid containing supplements or other dietary supplements for one month prior to the study (and duration of the study intervention)
- • Known allergies to the intervention foods
- • Consume more alcoholic beverages on average than 21 units/wk for men, or 14 units/wk for women (The UK Department of Health recommendations)
- • Pregnant, breast feeding, or planning a pregnancy (or having fertility treatment)
- • Unable to provide informed consent to participate in the study
About University Of East Anglia
The University of East Anglia (UEA) is a prominent research institution located in Norwich, UK, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. UEA fosters a collaborative environment that integrates academic research with clinical practice, enabling the development and execution of high-quality clinical trials. With a focus on improving patient outcomes, UEA engages in interdisciplinary research and partnerships with healthcare providers, ensuring that its clinical trials are designed to address pressing health challenges while adhering to rigorous ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norwich, Norfolk, United Kingdom
Patients applied
Trial Officials
Anne-Marie Minihane, PhD
Principal Investigator
Department of Nutrition, University of East Anglia, Norwich, U.K.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials